Wikidata

(Q61967478)

English

Safety, Tolerability And Mechanism Of Action Of Boswellic Acids (BA) In Multiple Sclerosis (SABA)

clinical trial

In more languages

Statements

short name
SABA (English)
0 references
title
Safety, Tolerability And Mechanism Of Action Of Boswellic Acids In Multiple Sclerosis and Clinically Isolated Syndrome: A MRI-Controlled, Multicenter, Baseline-To-Treatment, 32-Weeks, Open-Label, Phase IIa Trial (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
country
Germany
0 references
start time
September 2011
0 references
end time
December 2014
0 references
number of participants
29
0 references
minimum age
18 year
0 references
maximum age
65 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61967478&oldid=2114315328"